Spots Global Cancer Trial Database for pcr
Every month we try and update this database with for pcr cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Developing a Real-Time PCR Assay for Fusobacterium and Epidemiological Analysis of Tumor Patients | NCT06168513 | Fusobacterium I... | - | Zhujiang Hospital | ||
| I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer | NCT01042379 | Breast Neoplasm... Breast Cancer Breast Tumors Angiosarcoma TNBC - Triple-N... HER2-positive B... HER2-negative B... Hormone Recepto... Hormone Recepto... Early-stage Bre... Locally Advance... | Standard Therap... AMG 386 with or... AMG 479 (Ganitu... MK-2206 with or... AMG 386 and Tra... T-DM1 and Pertu... Pertuzumab and ... Ganetespib ABT-888 Neratinib PLX3397 Pembrolizumab -... Talazoparib plu... Patritumab and ... Pembrolizumab -... SGN-LIV1A Durvalumab plus... SD-101 + Pembro... Tucatinib plus ... Cemiplimab Cemiplimab plus... Trilaciclib wit... SYD985 ([vic-]t... Oral Paclitaxel... Oral Paclitaxel... Amcenestrant Amcenestrant + ... Amcenestrant + ... ARX788 ARX788 + Cemipl... VV1 + Cemiplima... Datopotamab der... Datopotamab der... Zanidatamab Lasofoxifene Z-endoxifen ARV-471 ARV-471 + Letro... | 18 Years - | QuantumLeap Healthcare Collaborative | |
| Developing a Real-Time PCR Assay for Fusobacterium and Epidemiological Analysis of Tumor Patients | NCT06168513 | Fusobacterium I... | - | Zhujiang Hospital | ||
| NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HER2+ Early Breast Cancer | NCT05704829 | HER2-positive E... | Trastuzumab der... Standard-of-Car... | 18 Years - | West German Study Group | |
| Therapeutic Effect Of Luteolin Natural Extract Versus Its Nanoparticles On Tongue Squamous Cell Carcinoma Cell Line | NCT03288298 | Tongue Neoplasm... Carcinoma | luteolin nano-luteolin | - | Cairo University | |
| Fulvestrant Versus Fulvestrant Plus Palbociclib in Operable Breast Cancer Responding to Fulvestrant | NCT03447132 | Breast Neoplasm... | Fulvestrant 500... Palbociclib 125... Goserelin 3.6 M... Placebos | 18 Years - | International Cancer Research Group, United Arab Emirates | |
| NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HER2+ Early Breast Cancer | NCT05704829 | HER2-positive E... | Trastuzumab der... Standard-of-Car... | 18 Years - | West German Study Group | |
| Docetaxel, Carboplatin, and Capecitabine as Treatment for Patients With Locally Advanced or Inflammatory Breast Cancer Before Surgery | NCT00251329 | Breast Cancer | neoadjuvant che... | 18 Years - | Cancer Research Network | |
| Genetic Diversity of Toxoplasma Gondii in Cancer Patients | NCT04834076 | Toxoplasma Gond... Cancer | ELISA PCR Sequencing | 1 Year - | Sohag University | |
| Therapeutic Effect Of Luteolin Natural Extract Versus Its Nanoparticles On Tongue Squamous Cell Carcinoma Cell Line | NCT03288298 | Tongue Neoplasm... Carcinoma | luteolin nano-luteolin | - | Cairo University | |
| Assess the Efficacy of Radiotherapy and Sequential Chemotherapy and AK104 Before TME Surgery for Local CRC（AK104-IIT-13） | NCT05794750 | Locally Advance... | AK104 injection TME surgery Capecitabine Oxaliplatin | 18 Years - 75 Years | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
| A Study of Liposomal Doxorubicin + Docetaxel + Trastuzumab + Metformin in Operable and Locally Advanced HER2 Positive Breast Cancer | NCT02488564 | HER-2 Positive ... | Liposomal doxor... Docetaxel Trastuzumab Metformin | 18 Years - 75 Years | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori | |
| Epstein-Barr Detection in Oral Cancer | NCT01039272 | Oral Cancer | 40 Years - | UPECLIN HC FM Botucatu Unesp | ||
| Smurf2 Gene Expression in Urinary Tract Tumors | NCT05134623 | Bladder Neoplas... | immunohistochem... | 18 Years - | Ziv Hospital | |
| Assess the Efficacy of Radiotherapy and Sequential Chemotherapy and AK104 Before TME Surgery for Local CRC（AK104-IIT-13） | NCT05794750 | Locally Advance... | AK104 injection TME surgery Capecitabine Oxaliplatin | 18 Years - 75 Years | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
| iCare3: Monitoring Circulating Cancer DNA After Chemotherapy in MDS and AML | NCT03138395 | Acute Leukemia Myelodysplastic... AML MDS | droplet digital... | 18 Years - 100 Years | University of Florida | |
| Epstein-Barr Detection in Oral Cancer | NCT01039272 | Oral Cancer | 40 Years - | UPECLIN HC FM Botucatu Unesp | ||
| iCare3: Monitoring Circulating Cancer DNA After Chemotherapy in MDS and AML | NCT03138395 | Acute Leukemia Myelodysplastic... AML MDS | droplet digital... | 18 Years - 100 Years | University of Florida | |
| NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HER2+ Early Breast Cancer | NCT05704829 | HER2-positive E... | Trastuzumab der... Standard-of-Car... | 18 Years - | West German Study Group | |
| Docetaxel, Carboplatin, and Capecitabine as Treatment for Patients With Locally Advanced or Inflammatory Breast Cancer Before Surgery | NCT00251329 | Breast Cancer | neoadjuvant che... | 18 Years - | Cancer Research Network | |
| Docetaxel, Carboplatin, and Capecitabine as Treatment for Patients With Locally Advanced or Inflammatory Breast Cancer Before Surgery | NCT00251329 | Breast Cancer | neoadjuvant che... | 18 Years - | Cancer Research Network | |
| Human EGFR Mutations Quantitative Detection Kit (Real-time Fluorescent PCR Method) | NCT02661009 | Non Small Cell ... EGFR-TKI Resist... EGFR-TKI Sensit... | 18 Years - 80 Years | GenoSaber | ||
| Evaluate the Auxiliary Diagnostic Value of Circulating Tumor Cells in Benign and Malignant Lung Nodules | NCT02653859 | Solitary Pulmon... | 18 Years - 80 Years | GenoSaber | ||
| Low-dose Apatinib Combined With Neoadjuvant Chemotherapy in the Treatment of Early Triple Negative Breast Cancer | NCT03243838 | Triple-Negative... | Apatinib | 18 Years - 70 Years | Guangdong Provincial People's Hospital | |
| Low-dose Apatinib Combined With Neoadjuvant Chemotherapy in the Treatment of Early Triple Negative Breast Cancer | NCT03243838 | Triple-Negative... | Apatinib | 18 Years - 70 Years | Guangdong Provincial People's Hospital | |
| Neoadjuvant Therapy for Locally Advanced Rectal Cancer With Fruquintinib, Toripalimab and SRT | NCT05763927 | Rectal Cancer | Fruquintinib Toripalimab Short-course ra... TME | 18 Years - 75 Years | West China Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
